Qube Research & Technologies LTD Veru Inc. Transaction History

Qube Research & Technologies LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.37 - $0.72 $2,329 - $4,532	-6,295 Reduced 67.61%	3,016 $2,000
Q4 2023 Feb 13, 2024	SELL	$0.67 - $1.17 $1,074 - $1,876	-1,604 Reduced 14.7%	9,311 $6,000
Q3 2023 Nov 13, 2023	SELL	$0.72 - $1.33 $87,288 - $161,241	-121,234 Reduced 91.74%	10,915 $7,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.49 $129,506 - $196,902	132,149 New	132,149 $157,000
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $9,412 - $21,827	921 Added 1.41%	66,282 $764,000
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $284,320 - $1.04 Million	65,361 New	65,361 $739,000
Q1 2022 May 09, 2022	SELL	$4.55 - $6.41 $56,647 - $79,804	-12,450 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$5.89 - $9.73 $73,330 - $121,138	12,450 New	12,450 $73,000
Q2 2020 Aug 14, 2020	SELL	$3.01 - $4.02 $858,638 - $1.15 Million	-285,262 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.58 - $4.58 $342,783 - $608,507	132,862 Added 87.18%	285,262 $933,000
Q4 2019 Feb 13, 2020	BUY	$1.86 - $3.35 $283,464 - $510,540	152,400 New	152,400 $511,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.